BENDAMUSTINE, BORTEZOMIB AND DEXAMETHASONE (BVD) IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA : THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM) 2009-01 PROTOCOL

被引：0
|
作者：
Rodon, P. [1 ]
Hulin, C. [2 ]
Pegourie, B. [2 ]
Tiab, M. [3 ]
Anglaret, B. [3 ]
Benboubker, L. [2 ]
Jardel, H. [3 ]
Decaux, O. [2 ]
Kolb, B. [2 ]
Roussel, M. [2 ]
Garderet, L. [4 ]
Leleu, X. [5 ]
Royer, B. [2 ]
Banos, A. [3 ]
Benramdane, R. [3 ]
Cony-Makhoul, P. [3 ]
Dib, M. [2 ]
Fontan, J. [2 ]
Stoppa, A. [6 ]
Traulle, C. [7 ]
Vilque, J. [8 ]
Moreau, P. [2 ]
Mathiot, C. [9 ]
Avet-Loiseau, H. [2 ]
机构：
[1] Ctr Hosp, Blois, France
[2] CHU, Nancy, France
[3] CH, La Roche Sur Yon, France
[4] Hop St Antoine, Paris, France
[5] CHRU, Lille, France
[6] Inst Paoli Calmettes, Marseille, France
[7] Hop Sud, Lyon, France
[8] Ctr Francois Baclesse, Caen, France
[9] Inst Curie, Paris, France
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0835
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [21] Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma
    Castelli, Roberto
    Pantaleo, Giuseppe
    Gallipoli, Paolo
    Gidaro, Antonio
    Arquati, Massimo
    Wu, Maddalena A.
    Deliliers, Giorgio Lambertenghi
    ANTI-CANCER DRUGS, 2015, 26 (10) : 1078 - 1082
  • [22] Salvage Therapy with Bortezomib and Dexamethasone in Elderly Patients with Relapsed Refractory Multiple Myeloma
    Castelli, Roberto
    Gallipoli, Paolo
    Gidaro, Antonio
    Maddalena, Wu
    Arquati, Massimo
    Deliliers, Giorgio Lambertenghi
    BLOOD, 2015, 126 (23)
  • [23] Double autologous transplantation improves survival of multiple myeloma patients: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome" (IFM 94).
    Attal, M
    Harousseau, JL
    Facon, T
    Guilhot, F
    Doyen, C
    Fuzibet, JG
    Monconduit, M
    Hullen, C
    Caillot, D
    Bouabdallah, R
    Voillat, L
    Sotto, JJ
    Grosbois, B
    Bataille, R
    BLOOD, 2002, 100 (11) : 5A - 6A
  • [24] SALVAGE THERAPY WITH BORTEZOMIB AND DEXAMETHASONE IN VERY ELDERLY PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA
    Castelli, R.
    Pantaleo, G.
    Gallipoli, P.
    Arquati, M.
    Wu, M. A.
    Deliliers, G. Lambertenghi
    Cicardi, M.
    HAEMATOLOGICA, 2015, 100 : 740 - 740
  • [25] Bortezomib asociated to dexamethasone in patients with relapsed/refractory multiple myeloma
    de la O, G. M. Maria
    Garcia-Delgado, R.
    Cuesta, M. A.
    Garrido, P.
    Dominguez, B.
    Hernandez, F.
    Galan, M.
    Sanchez, A.
    Garcia-Sanchez, R.
    Lopez, E.
    Perez, E.
    Bailen, A.
    Heiniger, A. I.
    Ramirez, G.
    Garcia, A.
    Jurado, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 482 - 483
  • [26] Ixazomib and daratumumab without dexamethasone (I-Dara) in elderly frail RRMM patients: A multicenter phase 2 study (IFM 2018-02) of the Intergroupe Francophone du Myelome (IFM).
    Leleu, Xavier
    Macro, Margaret
    Touzeau, Cyrille
    Mariette, Clara
    Manier, Salomon
    Brechignac, Sabine
    Vincent, Laure
    Hebraud, Benjamin
    Decaux, Olivier
    Schulmann, Samantha
    Lenoir, Caroline
    Godmer, Pascal
    Farge, Agathe
    Saint Paul, Laure Peyro
    Parienti, Jean-Jacques
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] IFM (Intergroupe francophone du myelome) recommendations for uniform interpretation of serum and urine protein electrophoresis in multiple myeloma diagnosis and follow-up
    Dejoie, Thomas
    Lakomy, Daniela
    Caillon, Helene
    Pegourie, Brigitte
    Decaux, Olivier
    ANNALES DE BIOLOGIE CLINIQUE, 2016, 74 (04) : 429 - 441
  • [28] Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM)
    Roussel, Murielle
    Moreau, Philippe
    Huynh, Anne
    Mary, Jean-Yves
    Danho, Clotaire
    Caillot, Denis
    Hulin, Cyrille
    Fruchart, Christophe
    Marit, Gerald
    Pegourie, Brigitte
    Lenain, Pascal
    Araujo, Carla
    Kolb, Brigitte
    Randriamalala, Edouard
    Royer, Bruno
    Stoppa, Anne-Marie
    Dib, Mammoun
    Dorvaux, Veronique
    Garderet, Laurent
    Mathiot, Claire
    Avet-Loiseau, Herve
    Harousseau, Jean-Luc
    Attal, Michel
    BLOOD, 2010, 115 (01) : 32 - 37
  • [29] Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma
    Poenisch, Wolfram
    Bourgeois, Malvina
    Moll, Barbara
    Heyn, Simone
    Jaekel, Nadja
    Wagner, Ina
    Rohrberg, Robert
    Hurtz, Hans-Juergen
    Schmalfeld, Marion
    Assmann, Michael
    Edelmann, Thomas
    Mohren, Martin
    Hoffmann, Franz Albert
    Becker, Cornelia
    Schwarzer, Andreas
    Schoenfelder, Uta
    Zehrfeld, Thomas
    Hensel, Gerald
    Loeschcke, Kerstin
    Krahl, Rainer
    Al Ali, Haifa
    Niederwieser, Dietger
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (03) : 499 - 508
  • [30] Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma
    Wolfram Pönisch
    Malvina Bourgeois
    Barbara Moll
    Simone Heyn
    Nadja Jäkel
    Ina Wagner
    Robert Rohrberg
    Hans-Jürgen Hurtz
    Marion Schmalfeld
    Michael Aßmann
    Thomas Edelmann
    Martin Mohren
    Franz Albert Hoffmann
    Cornelia Becker
    Andreas Schwarzer
    Uta Schönfelder
    Thomas Zehrfeld
    Gerald Hensel
    Kerstin Löschcke
    Rainer Krahl
    Haifa Al Ali
    Dietger Niederwieser
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 499 - 508
12345